Tailored guidance to apply the Estimand framework to Trials within Cohorts (TwiCs) studies

Publication date

2024-12

Authors

Gal, Roxanne
Kessels, Rob
Luijken, KimORCID 0000-0001-5192-8368
Daamen, Lois AORCID 0000-0001-9227-7178
Mink van der Molen, Dieuwke R
Gernaat, Sofie A MORCID 0000-0001-7828-1138
May, Anne MORCID 0000-0003-0643-3790
Verkooijen, Helena MORCID 0000-0001-9480-1623
van de Ven, Peter

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc

Abstract

Objective: The estimand framework offers a structured approach to define the treatment effect to be estimated in a clinical study. Defining the estimand upfront helps formulating the research question and informs study design, data collection and statistical analysis methods. Since the Trials within Cohorts (TwiCs) design has unique characteristics, the objective of this study is to describe considerations and provide guidance for formulating estimands for TwiCs studies. Methods: The key attributes of an estimand are the target population, treatments that are compared, the endpoint, intercurrent events and their handling, and the population-level summary measure. The estimand framework was applied retrospectively to two TwiCs studies: the SPONGE and UMBRELLA Fit trial. The aim is to demonstrate how the estimand framework can be implemented in TwiCs studies, thereby focusing on considerations relevant for defining the estimand. Three estimands were defined for both studies. For the SPONGE trial, estimators were derived. Results: Intercurrent events considered to occur exclusively or more frequently in TwiCs studies compared to conventional randomized trials included intervention refusal after randomization, misalignment of timing of routine cohort measurements and the intervention period, and participants in the control arm initiating treatments similar to the studied intervention. Considerations for handling refusal after randomization related to decisions on whether the target population should include all eligible participants or the subpopulation that would accept (or undergo) the intervention when offered. Considerations for handling treatment initiation in the control arm and misalignments of timing related to decisions on whether such events should be considered part of treatment policy or whether interest is in a hypothetical scenario where such events do not occur. Conclusion: The TwiCs study design has unique features that pose specific considerations when formulating an estimand. The examples in this study can provide guidance in the definition of estimands in future TwiCs studies.

Keywords

cmRCT, Cohort multiple randomized controlled trial, Estimand, Intercurrent events, Trials within Cohorts study, TwiCs, Epidemiology, Public Health, Environmental and Occupational Health, Infectious Diseases, Journal Article

Citation

Gal, R, Kessels, R, Luijken, K, Daamen, L A, Mink van der Molen, D R, Gernaat, S A M, May, A M, Verkooijen, H M & van de Ven, P M 2024, 'Tailored guidance to apply the Estimand framework to Trials within Cohorts (TwiCs) studies', Global Epidemiology, vol. 8, 100163. https://doi.org/10.1016/j.gloepi.2024.100163